尚荣医疗
(002551)
| 流通市值：18.09亿 | | | 总市值：25.03亿 |
| 流通股本：6.11亿 | | | 总股本：8.45亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 835,644,818.35 | 565,715,471.76 | 257,385,011.97 | 1,077,302,804.42 |
| 营业总成本 | 861,270,934.28 | 566,992,294.58 | 263,960,900.4 | 1,153,967,258.09 |
| 其他经营收益 | | | | |
| 营业利润 | -27,471,679.5 | -5,790,546.46 | 327,703.11 | -150,393,953.52 |
| 利润总额 | -26,690,155.54 | -3,527,536.31 | 279,590.99 | -157,580,880.74 |
| 净利润 | -37,005,679.86 | -13,303,576.73 | -1,234,337.32 | -146,208,017.02 |
| 每股收益 | | | | |
| 其他综合收益 | -17,142,208.21 | -11,839,557.62 | -3,968,922.52 | -10,430,756.03 |
| 综合收益总额 | -54,147,888.07 | -25,143,134.35 | -5,203,259.84 | -156,638,773.05 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,440,114,856.21 | 1,417,094,283.94 | 1,417,120,589.35 | 1,488,461,707.07 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,788,932,526.78 | 1,803,809,220.34 | 1,827,909,178.9 | 1,842,722,192.78 |
| 资产总计 | 3,229,047,382.99 | 3,220,903,504.28 | 3,245,029,768.25 | 3,331,183,899.85 |
| 流动负债: | | | | |
| 流动负债合计 | 591,445,482.25 | 551,883,964.82 | 550,033,798.85 | 626,870,565.26 |
| 非流动负债: | | | | |
| 非流动负债合计 | 77,197,642.79 | 79,610,527.79 | 84,647,083.22 | 88,761,188.57 |
| 负债合计 | 668,643,125.04 | 631,494,492.61 | 634,680,882.07 | 715,631,753.83 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,434,369,327.84 | 2,456,004,472.88 | 2,476,656,730.87 | 2,484,231,528.58 |
| 股东权益合计 | 2,560,404,257.95 | 2,589,409,011.67 | 2,610,348,886.18 | 2,615,552,146.02 |
| 负债和股东权益合计 | 3,229,047,382.99 | 3,220,903,504.28 | 3,245,029,768.25 | 3,331,183,899.85 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 825,859,729.07 | 432,902,913.6 | 265,176,382.48 | 1,229,672,501.95 |
| 经营活动现金流出小计 | 846,216,738.24 | 448,625,885 | 291,068,203.32 | 1,089,404,971 |
| 经营活动产生的现金流量净额 | -20,357,009.17 | -15,722,971.4 | -25,891,820.84 | 140,267,530.95 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 894,357,724.6 | 506,102,186.03 | 125,701,298.99 | 1,880,861,143.34 |
| 投资活动现金流出小计 | 896,372,083.89 | 513,975,878.72 | 141,561,293.11 | 1,897,673,158 |
| 投资活动产生的现金流量净额 | -2,014,359.29 | -7,873,692.69 | -15,859,994.12 | -16,812,014.66 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 53,419,000 | 19,419,000 | 10,589,100.13 | 51,150,000 |
| 筹资活动现金流出小计 | 106,537,952.76 | 47,543,844.44 | 426,833.33 | 343,181,842.28 |
| 筹资活动产生的现金流量净额 | -53,118,952.76 | -28,124,844.44 | 10,162,266.8 | -292,031,842.28 |
| 汇率变动对现金及现金等价物的影响 | 412,600.05 | -1,765,282.18 | -17,430,667.02 | 11,954,306.18 |
| 现金及现金等价物净增加额 | -75,077,721.17 | -53,486,790.71 | -49,020,215.18 | -156,622,019.81 |
| 期末现金及现金等价物余额 | 222,287,409.24 | 243,878,339.7 | 248,344,915.23 | 297,365,130.41 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -53,486,790.71 | - | -156,622,019.81 |